Skip to main content
CDC Website

Community Based Organizations

Thinking About Starting a Supportive Housing Program? Recommendations and Considerations for the Planning Process

This guideline, Informed by conversations with current housing and harm reduction service providers, Thinking About Starting a Supportive Housing Program? Recommendations and Considerations for the Planning Process may be used to help inform programmatic development for supportive housing. It is intended for governmental and community-based organizations that are interested in developing housing programs within their organization or collaborating with other partners in their communities.

Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use.

Linking Eligibility Across the Ryan White HIV/AIDS Program Parts - Dissemination Assistance Provider

This notice announces the opportunity to apply for funding under the Linking Eligibility Across the Ryan White HIV/AIDS Program (RWHAP) Parts - Dissemination Assistance Provider program. The Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB) will fund one cooperative agreement for up to two years to: 1. Examine current eligibility determination and confirmation processes in place across all RWHAP Parts and identify administrative, technical, and legal barriers facing providers and clients. 2.

Strengthening immunization program implementation in sub-national consequential geographies

The purpose of this NOFO is to increase immunization program capacity in high priority countries and targeted sub-national areas to identify underserved populations and develop tailored interventions to vaccinate underserved populations; implement comprehensive vaccine preventable disease (VPD) surveillance systems; improve preparedness and response to outbreaks of VPDs; and strengthen quality and sustainability of immunization delivery systems.

Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR

This NOFO aims to enhance Central Asia's capacity to provide high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information (SI) programs. The goal is to achieve epidemic control by 2030, following international standards (e.g., UNAIDS, International Health Regulations), and adapted to the local context. Based on PEPFAR's 5x3 Strategic Framework (September 2022), the focus is on leveraging investments to build resilient health systems that can effectively respond to public health threats.

Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)

HIV infection and substance use are comorbid conditions that bidirectionally and synergistically influence the deleterious outcomes in people who suffer from substance use disorders (SUD). The persistence and transcriptional reactivation of HIV lead to the development of neuropathological complications. Strategies to address viral latency include silencing of HIV transcription and reactivation and clearance.

Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R21 Clinical Trial Not Allowed)

HIV infection and substance use are comorbid conditions that bidirectionally and synergistically influence the deleterious outcomes in people who suffer from substance use disorders (SUD). The persistence and transcriptional reactivation of HIV lead to the development of neuropathological complications. Strategies to address viral latency include silencing of HIV transcription and reactivation and clearance.

What motivated you to join the Let’s Stop HIV Together campaign?

On November 30, NASTAD hosted a webinar, “Program Evaluation – Just the Basics.”This webinar provided a basic overview of program evaluation. It covered the importance of evaluation on the success of a program, common misconceptions about evaluation, and different kinds of evaluation commonly used by HIV prevention programs. 

Topics discussed were the general principles and key components of program evaluation processes using CDC’s framework for program evaluation, practical examples of evaluation tools including SMARTIE objectives, and logic models. 

Black Women Researchers and PrEP Webinar - Part Two

This webinar series is a partnership with the Atlanta Black Women Leaders On PrEP and NASTAD. The webinars provide a platform for Black women to share their research with a broader audience and discuss ways the public health community can provide support for their efforts. 

Black Women Researchers and PrEP Webinar - Part One

This webinar series is a partnership with the Atlanta Black Women Leaders On PrEP and NASTAD. The webinars provide a platform for Black women to share their research with a broader audience and discuss ways the public health community can provide support for their efforts.